Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis.

Irene BargelliniValentina LorenzoniGiulia LorenzoniPaola ScaliseGianni AndreozziElena BozziLuigi GiorgiRosa CervelliRossella ScandiffioOrsola PerroneDonato Vito MecciaAntonio BoccuzziFrancesco DaviddiAntonio CicorelliAlessandro LunardiLaura CrocettiGiuseppe TurchettiRoberto Cioni

Published in: European radiology (2021)

• Compared to lipiodol-TACE, DEB-TACE is better tolerated and has reduced side effects, which translates into shorter hospitalization. • When complete radiological response according to the mRECIST is obtained 1 month after the procedure, DEB-TACE offers a more durable local tumor control compared to lipiodol-TACE. • In these patients, the longer duration of response after DEB-TACE translates into a lower number of re-interventions.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
physical activity